Myomancy ADHD, Dyslexia and Autism

Montague Diagnostics who run a innovative light  treatment from Russia have announced a full trial of their system on dyslexics.  Participants who have all been formally assessed by a third party for dyslexia will undergo treatment using the Virtual Scanner for up to 6 months and at the end of the process be reassessed for dyslexia.
Graham Ewing of Montague says "We do not expect to cure dyslexia. Anyone claiming cure is exaggerating the possibilities for their approaches. We are treating the underlying health issues which are responsible for the dyslexic symptoms. We expect to improve a person’s sleeping patterns, their ability to concentrate, their overall health and thereby their ability to learn. The current explanation is that Virtual Scanning technology improves the production of human growth hormone and related immunochemicals which have an effect upon the production of neurons and synapse formation in the brain. "
Places on the trial, which is free, may be available. Please contact Graham Ewing for more details.